Acute renal response to large doses of intravenous prednisolone in kidney homograft recipients and in normal subjects by Popovtzer, MM et al.
AGGTE REXAL obpml~pb TO 
LARGE DOSES OF INTRAVENOlTS 
PREDXISOLONE IN KIDNEY 
HONIOGRAFT RECIPIEi'iTS AND 
IX XOIDIAL SUB.TEeTS 
MORDECA T :::.1. POPOVTZER 
WULF F. PINGGERA 
JOU:-J ROBINETTE 
.TOSEPH Jr. HOLMES 
CHARLES G. JIALGRIMSON 
and 
THOMAS E. STARZL 
Denver, Colo. 
FI"OJll the Deparbnents of l\Iedieine an(1 Surgery. 
,'niversity of Colora(lo Medical Center 
Reprintecl from 
THE .JOURNAL OF LABORATORY AND 
CL INICAL MEDICINE 
St. Louis 
'-01. 78, ))"0. 1, Pagps 39-52, July, 1971 
(Copyright ~ B,l by The C. V. Mosby Company) 
\ Pt'intec1 in the l'. S. ,\.) 
Acute renal response to large doses of 
intravenous prednisolone in kidney homograft recipients 
and in normal subiects 
MORDECAI M. POPOVTZER, WULF F. PINGGERA,* 
JOHN ROBINETTE, JOSEPH H. HOLMES, CHARLES G. 
HALGRIMSON, and THOMAS E. STARZL Denver, Colo. 
The immediate renal response to large intravenous doses of prednisolone was studied 
in 18 kidney homograft recipients and in 6 normal subjects. Clearance rates of inulin 
(C IN), creatinine ICcR), p-aminohippurate (CPAH), and electrolytes were measured over 
3 one-hour periods following intravenous infusion of prednisolone (1 Gm.) and 
compared with corresponding clearance rates after a placebo infusion. CIN, CCR, and 
C ' CPAH rates and t~F ratios exhibited a substantial decrease during all collection 
CIN 
periods following the infusion of prednisolone, both in the normal subjects and in 
the patients. Fractional excretion of potassium E~F increased in a progressive fashion 
CIN 
reaching peak values after 3 hours. Biphasic variations were observed in the 
fractiona I excretion of sodium (CNA ); an increase during the first hour was followed 
CIN 
by a decrease during the third hour. The changes in the fractional excretions of 
ultraflltrable calcium E~ca \ , ultrafiltrable magnesium (CM9 ), and phosphorus 
CINi CIN 
E~F were minimal. Normal subjects exhibited significant decreases in CCd and CIN CIN 
C ~ following the infusion of prednisolone; there was no significant change in the 
CIN 
patients. ~ increased significantly both in the normal subjects and in the patients. 
CIN 
These results indicate that acute suppression of kidney function is a general renal 
response to large doses of glucocorticoids. The marked decrease in the creatinine 
clearance ratio E~~:F observed after the administration of prednisolone is consistent 
with a depressed tubular secretion of creatinine and emphasizes the inadequacy of CCR 
as an indication of glomerular filtration rate (GFR) under conditions in which large 
doses of glucocorticoids are employed. 
From the Departments of Medicine and Surgery, University of Colorado Medical Center. 
This work was supported by grants from the United States Public Health Service, Nos. 
AM-06344, AM-07772, FR-00051, AI, 04152, FR-00069, AM-12148, and AI-AM-08898. 
Received for publication Jan. 7, 1971. 
Accepted for publication March 30, 1971. 
Reprint requests: Dr. M. Popovtzer, University of Colorado Medical Center, 4200 E. 9th 
Ave., Denver. Colo. 80220. 
·Dr. Pinggera was supported by the Max Kade Foundation. 
39 
4 0 Popovtzer et al. J. Lab. Clin. Med. 
July, 1971 
Intermittent large intravenous doses of glucocorticoids have been employed 
in treatment of homograft recipients as a supplement to the maintenance im-
munosuppression regimen. l . a The benefit accruing from this combined manage-
ment has not been established fully as yet; however, clinicap-a and experimental4 
observations support its possible therapeutic effect. 
The response of renal homografts to large doses of glucocorticoids may 
reflect at least 2 different aspects of hormonal action: (1) immunologic suppres-
sion of homograft rejection with a resulting improvement in renal function and 
(2) direct (nonimmunologic) effect on renal hemodynamics and/or tubular 
transport. 
The present study was undertaken to evaluate the acute renal response to 
large doses of glucocorticoids in recipients of kidney homo grafts and in a control 
group of normal subjects. 
Methods 
Eighteen patients and 6 normal subjects wero investigated. The patients were managed 
with intermittent intravenous prednisolone, in addition to oral maintenance doses of prednisone 
and azathioprine (Table I). In most patients, the kidney function, as measured by daily 
creatinine clearances, was stable within several days preceding the study. All patients and 
normal individuals were given prednisolone sodium phosphate (1 Gm.) (Hydeltrasol) intra-
venously in about 50 ml. of normal saline over one hour. Fourteen of 18 patients and all 6 
normal individuals also received intravenously normal saline with placebo (50 m!.) which 
consisted of the liquid vehicle of prednisolone. The experiments with prednisolone and placebo 
were no more than one week apart. 
Clearanoe studies. The clearance studies were conducted in a fasting state, at the same 
time of day, both in the prednisolone and in the placebo experiments. An oral water load 
was given prior to the study (20 m!. of tap water per kilogram of body weight). During the 
study, urine volumes were replaced with equal amounts of water. In patients whose water intake 
had been restricted, the water load was reduced accordingly. Priming doses of inulin (IN) 
and p-aminohippurate (P AH) based on body weights were injected intravenously and were 
followed by sustaining doses. The latter were infused with a Sigmamotor pump delivering 1 
m!. of normal saline per minute, with IN and P AH in amounts calculated on the basis of the 
presumptive glomerular filtration rates (GFR). Forty-five minutes were allowed for equilibra· 
tion before timed urine collections were started. Each collection period lasted 30 to 60 minutes, 
and a blood sample was obtained at its midpoint. The patients and the normal individuals 
remained supine during the whole study with the exception of assuming upright positions for 
voluntary voiding. Following at least 2 control collections, either prednisolone or placebo in-
fusion was started and urine samples were collected during the following 3 hours. All serum 
and urine specimens were assayed for IN, creatinine (CR), PAH, sodium (Na), potassium (K), 
phosphorus (P), calcium (Ca), and magnesium (Mg). IN,5 CR,s and PAH7 were determined 
by a Tcchnicon AutoAnalyzer. Na and K were measured with an Instrumentation Laboratory 
Flame Photometer Model 143. Total and ultrafiltrable Ca and Mg were measured with the 
Norelco Unicam Atomic Absorption Spectrophotometer. All samples and standards were diluted 
with lanthanum chloride to prevent phosphate and protein interference. Ultrafiltrates of serum 
were prepared with the use of colloidian bags.s Inorganic P was measured utilizing the 
methodology developed by the American Monitor CO.9 
Results 
The individual baseline data representing the average values of the control 
periods of all patients and normal subjects are shown in Table II. Ca and Mg 
clearances were determined in terms of the ultrafiltrable fractions of these 
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Table I. Clinical data for all patients and control subjects 
Body Prednisone 
surface Daysofter (mg. per 
Subjects Age Sex (Mt) Diagnosis" transplant Donort day) 
Patients 
C. B. 38 M 1.85 CGN 60 C 20 
S.J. 37 M 1.71 CGN 14 C 120 
S. E. 38 M 1.51 CGN 60 R 45 
W.D. 34 M 1.75 CGN 14 C 120 
M.P. 35 M 1.73 CGN 457 R 25 
L.C. 18 F 1.45 CGN 611 R 25 
'r.w. 38 111 1.72 PN 92 R 20 
J.M. 45 M 2.00 CGN 91 C 20 
B. J. 35 M 1.91 CGN 61 C 40 
G.C. 14 111 1.30 CGN 30 R 60 
C. E. 19 M 1.62 CGN 5 R 170 
H.R. 40 M 1.93 CGN 213 R 25 
L.E. 33 M 1.64 CGN 488 R 35 
C.D. 34 M 1.89 PN 42 R 25 
KR. 45 11 1.76 CGN 153 R 90 
T. S. 14 F 1.28 CGN 21 C 60 
D.J. 23 M 1.79 CGN 2,007 R 40 
J.C. 41 11 1.95 PCK 154 C 45 
Normal 
C.A. 31 M 2.08 
P.M. 35 M 1.79 
R.J. 29 M 1.90 
A.G. 40 M 1.78 
P.W. 31 11 1.72 
G.S. 30 M 1.73 
·(CGN) Chronic glomerulonephritis; (PCK) polycystic kidneys; (PN) chronic pyelone-
phritis. 
t(C) Cadaver; (R) related. 
cations. All clearance values are for a body surface area of 1.73 square meters. 
The clearance data were divided into 4 consecutive periods: (1) one control 
clearance which was the average of all preinfusion clearances, (2) 3 postinfusion 
clearances which were hourly averages of clearances determined from urine 
collections started after the beginning of the infusion and completed 3 hours 
later. The mean changes in the clearances of inulin (C rN ), creatinine (CCR), and 
p-aminohippurate (CPAH ) associated with prednisolone and placebo infusions 
are presented graphically in Figs. 1, A and B, 2, A and B, and 3, A and B, which 
illustrate sequential deviations of the postinfusion clearances from the prein-
. postinfusion clearance fUSIOn clearance rates as the per cents of control: x 100. 
control clearance 
All results represent mean values and standard deviation for each group. The 
individual absolute clearance values, CIN, CCR, and CPAH, during the 4 consecu-
tive collection periods with prednisolone infusion are shown on Table III. Renal 
handling of Na, K, Ca, Mg, and P are expressed in terms of their fractional 
42 Popovtzer ct al. J. Lab. Clin. Med. 
July, 1971 
Table II. Control clearances (C) in all patients and in normal subjects 
CIN CeR Cl'AH SN.* CNa S * CK K 
Subjects (ml./min.) (ml./min.) (ml./min.) (mEq./L.) (ml./min.) (mEq./L.) (ml./min.; 
mat~ents 
C.B. 89 123 490 127 1.00 3.1 28.5 
S.3. 76 78 465 127 1.73 3.3 15.7 
S.E. 76 94 365 144 lAO 4.3 25.2 
W.D. 59 84 335 133 1.43 4.0 19.0 
M.P. 57 76 410 132 2.24 2.5 13.8 
L.C. 69 80 650 135 1.01 3.3 11.1 
T.W. 54 91 354 143 1048 3.8 18.8 
3.M. 45 64 310 134 1.49 3.6 9.2 
B.3. 45 75 255 131 1.15 3.3 28.0 
G.C. 66 95 580 132 0.99 4.1 41.0 
C.E. 50 66 360 141 0.11 4.3 16.0 
R.R. 39 50 145 135 2.59 3.1 40.5 
L.E. 41 65 O~S 141 2.34 3.1 7.5 
C.D. 34 94 191 132 1.00 2.8 22.6 
K.R. 23 35 165 141 1.49 3.7 17.3 
T.S. 27 37 242 142 0,48 3.3 18.5 
D.3. 19 36 294 134 0.56 3.1 7.3 
3.C. 13 22 88 138 0.76 3.4 11.6 
Mean 49.0 70.3 323.6 135.8 1.29 3.4 19.5 
± S.D. 21.3 26.2 153.3 5.3 0.6 0.5 10.0 
Normal 
Mean 105.2 126.3 543.8 140.9 1.4 3.54 15.76 
± S.D. 10.5 8.9 42.3 0.97 0.5 0.23 10.8 
• (SNa) Sodium concentration in the serum; (SK) potassium concentration in the serum; (Sp) 
calcium concentration in the serum; (SMg) magnesium concentration in the serum; (DSMg) 
excretions: CNa , CK , CCa , CM ::- , Cp . The quantitative assessment of the alteration 
CrN CrN CrN CIN CIN 
in renal handling of these ions was attained by subtracting the preinfusion 
fractional excretion from the postinfusion values, with results indicating either 
increments or decrements in the fractional excretion of a given ion. 
The analysis of the variations associated with prednisolone infusion is based 
on the comparison of the observations during prednisolone infusion with the 
corresponding observations during placebo infusion. The determination of 
significant differences between parallel observation periods was made with the 
use of the Student's t test. 
Inulin clearances. CIN rose progressively following placebo infusion both in 
the patients and in the normal subjects. The CIN rates during the 3 consecutive 
hourly periods in patients equalled (mean ± S.D.) 106 ± 11, 114 ± 24, and 117 ± 23 
per cent, and in the normal subjects, 106 ± 6, 110 ± 9, and 106 ± 9 per cent of the 
preinfusion control CIN. Following prednisolone infusion, CIN decreased in both 
groups. The values in the patient were 80 ± 14, 87 ± 19, and 88 ± 18 per cent, and 
in the normal subjects, 88 ± 2, 92 ± 12, and 93 ± 9 per cent of the preinfusion 
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Sp* 
(mg.j 
100 mI.) 
2.1 
1.6 
0.4 
1.8 
2.2 
3.7 
1.6 
2.8 
2.3 
3.7 
1.9 
3.5 
2.4 
2.3 
2.1 
2.0 
4.6 
3.5 
2.4 
1.0 
2.89 
0.89 
Cp 
(ml./min.) 
3.6 
0.8 
36.0 
33.5 
12.5 
18.0 
19.4 
13.6 
27.0 
6.3 
41.3 
9.8 
4.6 
1.7 
6.5 
17.8 
11.9 
9.4 
15.2 
12.1 
17.8 
5.8 
S * Ca DSca* 
(mg./ (mg.j 
100 mI.} 100 mI.} 
10.0 4.7 
9.6 4.7 
8.2 4.2 
12.4 5.6 
10.0 4.6 
9.9 4.7 
9.2 4.1 
11.0 4.3 
9.2 3.8 
12.4 5.2 
9.6 5.0 
10.0 4.4 
10.9 3.8 
10.2 4.1 
9.6 5.0 
9.2 5.7 
10.4 4.0 
10.1 4.6 
1.0 0.5 
10.12 4.47 
0.2 0.21 
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SMg* DSMo" 
Cea (mg./ (mg./ CJr• 
(ml./min.) 100 mI.} 100 mI.} (ml./min.) 
3.40 2.6 1.6 16.2 
1.70 2.2 1.4 9.6 
11.40 2.2 1.6 12.6 
10.00 3.1 2.1 17.4 
3.45 1.9 1.3 4.3 
5.31 2.5 1.5 11.) 
0.58 1.9 1.2 8.3 
0.73 2.7 1.4 9.:) 
0.75 3.3 1.6 29.9 
5.40 2.3 1.9 18.1 
5.60 2.6 1.7 16.2 
0.94 1.8 17.4 
2.16 3.0 1.5 9.6 
1.82 3.4 1.7 11.6 
0.24 2.7 1.7 2.4 
4.85 2.3 1.9 16.4 
1.86 2.6 1.5 10.5 
3.5 2.6 1.6 13.0 
3.2 0.4 0.3 6.3 
4.9 2.0 1.51 8.2 
2.6 0.24 0.08 2.8 
phosphorus concentration in the serum; (Sea) calcium concentration in the serum; (DSe.) diffusible 
diffusible magnesium concentration in the serum. 
control eIN• The differences between the eIN variations during prednisolone and 
placebo infusion were significant in all periods in both groups (Fig. 1, A and B) . 
The average discrepancies between the corresponding variations in eIN during 
the 3 hours following prednisolone and placebo infusions were 26, 27, and 29 
per cent in the patients and 18, 18, and 13 per cent in the normal subjects. 
Creatinine clearances. Following placebo infusion, the values of eOR in the 
patients equalled 104 ± 17, 109 ± 19, and 107 ± 20 per cent, and in the normal 
individuals, 106 ± 4, 109 ± 6, and 109 ± 7 per cent of prcinfusion clearances. The 
corresponding variations after prednisolone infusion were: in the patients, 
73 ± 13, 74 ± 13, and 73 ± 13 per cent, and in the normal individuals, 84 ± 7, 
86 ± 4, and 86 ± 5 per cent of the preinfusion eOR (Fig. 2, A and B). The serum 
levels of creatinine remained constant throughout the study. 
Creatinine: inulin clearance ratios. eOR varied minimally after placebo in-
erN 
fusion, whereas following prednisolone the ratio decreased markedly; in the 
patients, the decrements in eOR during the 3 postinfusion periods were -0.16 ± 
erN 
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Table III. Clearance rates of inulin (C IN ), creatinine (CCR), and 
p-aminohippurate (CPAR ) before and after prednisolone infusion 
CIN COR CPAH 
(ml./min.) (ml./min.) (ml./min. ) 
Can· I I I con-I I I Con- I 1* I 2 I Subjects trol 1* 2 3 trol 1* 2 3 trol 3 , 
Pattents 
C.B. 89 68 83 78 123 82 90 114 490 410 443 355 
S.J. 76 53 58 85 78 56 53 51 465 385 405 500 
S.E. 76 35 21 51 94 37 36 36 365 188 265 2i5 
W.D. 59 56 53 45 84 69 60 42 335 315 315 26. 
M.P. 57 39 46 49 76 52 68 64 410 395 315 3i, 
L.C. 69 65 67 72 80 62 67 69 650 582 600 5iD 
T.W. 54 40 54 35 91 62 86 55 354 247 384 246 
J.M. 45 40 41 50 64 49 45 57 310 265 266 365 
B. J. 45 38 44 44 75 50 52 49 255 230 275 287 
G.C. 66 54 46 46 95 68 55 54 580 470 R"~ ~f 400 
C.E. 50 43 37 38 66 57 56 61 360 359 460 402 
H.R. 39 33 34 22 50 39 40 39 145 127 142 .4 
L.E. 41 31 3. 38 65 59 53 45 226 182 204 204 
C.D. 34 27 33 34 94 45 56 47 191 126 19i 234 
K.R. 23 17 21 22 35 23 28 24 165 110 153 109 
T.S. 27 26 21 23 37 32 28 30 242 222 215 205 
D.J. 19 18 19 18 36 32 25 25 194 176 165 134 
J.C. 13 13 12 10 22 18 18 14 88 ~~ 86 45 II 
Normal 
C.A. 112 96 108 ]06 130 95 110 110 610 445 495 545 
P. M. 120 no 95 109 125 110 1D3 105 490 480 4,0 475 
R. J. 105 88 79 84 122 112 103 98 553 510 480 465 
A.G. 106 95 84 97 118 101 110 116 525 435 475 495 
P.W. 98 88 98 97 142 124 115 118 510 505 455 465 
G. S. 89 79 93 84 126 99 116 116 543 437 535 50;') 
·Number of hours after the beginning of the infusion. 
0.20, -0.28 ± 0.19, and -0.35 ± 0.18, and in the normal individuals, the decrements 
were -0.16 ± 0.14, -0.17 ± 0.10, and -0.20 ± 0.14. The difference between the 
placebo and prednisolone infusion periods with respect to the changes in eCR 
CD; 
were highly significant (Fig. 3, A ancI B) . 
Effective renal plasma flow. The variations in CUR pursued a course similar 
to that in CIN and CCR' During the placebo infusion in the patients, CPAR valnes 
were equal to: 99 ± 15, 106 ± 28, and 113 ± 29 per cent and in the normal 
individuals, 107 ± 12, 107 ± 16, ancI110 ± 17 per cent of the preinfusion control 
values, whereas following prednisolone infusion, the CUR values in the patients 
were 83 ± 12, 84 ± 19, and 86 ± 23 per cent and in the normal individuals, 87 ± 9, 
85 ± 7, and 91 ± 3 per cent of the preinfusion control clearances (Fig. 4, A and 
B). The average decreases in CUR after prednisolone infusion (using the values 
after placebo infusion as reference points) were: in the patients, 16, 20, and 27 
per cent and in the normal individuals, 20, 18, and 19 per cent of control. 
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3 
HOURS 
Fig. 1. Changes in inulin clearances (C,N) during 3 one· hour periods following prednisolone 
and placebo infusions. The results are presented as per cents of control clearances. The values 
shown are mean ± S.D. for (..4) all patients and (B) all normal subjects. 
A 
140 
or 
" U 100 
-' 0 
oc 
>-
z 
0 
60 
<0,0005 <0,0005 <0.0005 
U 
LL 
0 
11'- ~ PLACEBO 0-0 PREDNISOLONE 181 PLACEBO 0-0 PREDNISOLONE 
3 
HOURS HOURS 
Fig. 2. Changes in creatinine ClcarallCeS (CeR ) during 3 one-hour periods following prednisolone 
and placebo infusions. The results are presented as per cents of control clearances. The values 
shown are mean ± S.D. for (Li) all patients and (B) all normal subjects. 
Fractional exc1"etion of sodium. The alterations in renal handling of Na 
followed a biphasic pattern: CNa increased during the first hour, returned to the 
CIN 
control baseline value during the second hour, and decreased during the third 
hour. These changes were seen both in the patients and in the normal individuals; 
however, in the latter they were less prominent (Table IV). 
Fractional excretion of potassium. In both groups, a decline in CK was 
CrN 
noticed following placebo infusion. After prednisolone infusion, CK increased 
CrN 
progressively during the postinfusion hours (Table IV). When the variations in 
Cl{ were plotted against those in CNa for each pair of individual periods and for 
CrN CrN 
all periods together, the relationships were not significant. The serum concentra-
tions of K showed no significant change during the placebo and the prednisolone 
infusion in all 3 periods, both in the patients and in the normal individuals. 
Fractional excretion of ultrafiltrable calcium. In the normal individuals 
there was a significant decrement in Cca during the first and second hours 
CIN 
following prednisolone infusion (Table IV). The alterations in ultrafiltrable 
serum Ca levels in both groups were not significant (Table IV). 
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0.4 0.4 
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EJ PLACEBO .-. PREDNISOLONE EJ PLACEBO .-. PREDNISOLONE 
HOURS HOURS 
F-ig. 3. Changes in fractional excretions of creatinine (CCR) during 3 one-hour periods follow-
CIN 
ing prednisolone and placebo infusions_ The results are presented as the difference between 
the preinfusion and postinfusion values for (Ll) patients and (B) normal subjects. 
A B 
140 
<0.0005 <0.025 <0,005 0:::0,0005 <0,01 <0.025 
EJ PLACEBO .-. PREDNISOLONE c:J PLACEBO .-. PREDNISOLONE 
2 
HOURS HOURS 
Fig. 4. Changes in p-amiuohippurate clearances (CPAR ) during 3 one-hour periods following 
prednisolone and placebo infusions. The results are presented as per cents of control clearances. 
The values shown are mean ± S.D. for (Ll) all patients and (B) all normal subjects. 
Fractional excretion of ultrajiltrable magnesilnn_ Following placebo infusion, 
C1III: decreased in the patients and increased in the normal individuals. CMII: 
Crn Crn 
,vas not affected significantly by prednisolone infusion in the patients (first and 
second hours), whereas a significant decrement was noticed in the normal in-
dividuals (Table IV). No significant changes in the ultrafiltrable serum Mg 
levels were seen in both groups. 
Fractional excretion of phosphorus. Following placebo infusion, the varia-
tions in ~ were minimal in both groups. Significant increments in CP were 
CIN GIN 
noticed in the patients during the first hour and in the normal individuals during 
the first and second hours following prednisolone infusion (Table IV). The 
serum levels of P remained unchanged in the patients, whereas small but 
significant decrements were noticed in the normal subjects during the second 
(-0.4 ± 0.5 mg. per 100 ml.) and third (-0.7 ± 0.5 mg. per 100 ml.) postinfusion 
periods. 
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Table IV. Changes in fractional excretions of sodium ( CNU), potassium CIN 
( CK), calcium (CCIl" magnesium E~~fgFI and phosphous CrN CIN ) CIN E ~pF (mean eIN 
± S.D.) after placebo and prednisolone infusions 
C1-~-D 
Cn; 
Placebo 
-0.002 
:1:0.044 
Prednisolone +0.010 
P 
Placebo 
:1:0.024 
< 0.025 
-0.009 
:1:0.130 
Prednisolone +0.090 
:1:0.140 
Patients 
:8 
-0.002 
:l:O.OHi 
-0.004 
:1:0.010 
NSt 
-0.075 
:1:0.150 
+0.168 
:1:0.183 
s 
-0.001 
:1:0.010 
-0.010 
:1:0.019 
-0.001 
:1:0.004 
+0.001 
:1:0.002 
< 0.0005 < 0.05 
-0.110 
:1:0.180 
+0.218 
:1:0.271 
-0.050 
:1:0.100 
+0.006 
:1:0.010 
-0.005 
:1:0.005 
-0.002 
:1:0.002 
NS 
-0.097 
:1:0.112 
+0.095 
:1:0.200 
3 
-0.002 
:1:0.004 
-0.004 
:1:0.003 
< 0.05 
-0.110 
:1:0.080 
+0.160 
:1:0.270 
P < 0.0005 < 0.0005 < 0.0005 < 0.0005 < 0.01 < 0.010 
+0.003 
:1:0.007 
C" ~-
CI~ 
Placebo 
+0.002 
:1:0.026 
Prednisolone -0.008 
:1:0.036 
P NS 
Placeho 
-0.038 
:1:0.150 
Prednisolone -0.006 
P 
Placebo 
:1:0.051 
NS 
-0.013 
:1:0.110 
Prednisolone +0.065 
:1:0.081 
P < 0.0025 
-0.015 
:1:0.022 
-0.010 
:1:0.033 
NS 
-0.044 
:1:0.130 
+0.015 
:1:0.093 
NS 
-0.012 
:1:0.187 
+0.009 
:1:0.109 
NS 
-0.033 
:1:0.032 
-0.010 
:1:0.030 
NS 
-0.036 
:1:0.045 
+0.010 
:1:0.093 
< 0.005 
+0.030 
:1:0.250 
+0.028 
:1:0.134 
NS 
"Number of hours after the beginning of the infusion. 
t(l1) Change from control values (increment or decrement). 
tNot significant. 
Discussion 
+0.005 
:1:0.007 
-0.007 
:1:0.014 
< 0.05 
+0.020 
:1:0.03'0 
-0.001 
:1:0.039 
< 0.05 
+0.001 
:1:0.053 
+0:061 
:1:0.052 
< 0.05 
+0.001 
:1:0.010 
-0.013 -0.005 
:1:0.019 :1:0.022 
< 0.05 < 0.05 
+0.024 
:1:0.036 
-0.010 
:1:0.044 
+0.015 
:1:0.028 
-0.026 
±0.047 
< 0.0025 < 0.005 
-0.025 
:1:0.065 
+0.064 
:1:0.007 
< 0.001 
-0.034 
:1:0.072 
-0.020 
:1:0.031 
NS 
The present study demonstrated a significant effect of large intravenous doses 
of prednisolone on certain aspects of renal function. The most striking finding 
was prompt reduction in GFR (CIN ), effective renal plasma flow (CPAH ), and 
creatinine clearance (CCR)' The present observations were limited to the immedi-
ate action of the large dose of prednisolone, whereas evaluation of the clinical 
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consequences of this treatment, which might require longer follow-up studies, 
was obviously beyond the scope of the present investigation. 
In previously reported studies, glomerular filtration did not vary consider-
ably following acute administration of glucocorticoids to normal subjects.iO- l4 
However, acute increase in filtration rate was observed in states of glucocorticoid 
deficiency and/or salt depletion.12, 15-17 Evidently the acute suppression of renal 
function observed in the present study was not specific to transplanted kidneys, 
but seemingly it represents general renal response to large doses of glucocorti-
coids. 
The fall in OPAH could be due to one or seycral different mechanisms: (1) 
decrease in total renal plasma flow, (2) redistribution of renal plasma flow with-
out changes in its total rate, (3) markedly decreased P AH extraction, and actual 
increase in total renal plasma flow with a decrease in GFR due to an efferent 
arteriolar dilatation, and (4) interference with tubular transport of P AH. 
Total renal plasma flow was not measured in our study; neither were P AH 
extraction ratios and TmpAII measured. In the absence of the above measure-
ments, the interpretation of the observed changes in OPAll is difficult. The avail-
able information regarding acute effect of glucocorticoids on renal plasma flow 
is scarce. Acute administration of glucocorticoids (hydrocortisone 10 mg. per 
kilogram) failed to alter total renal vascular resistance in experimental animals. JS 
Solu-Medrol (40 mg.), injected directly into one renal artery of a dog, had a 
negligible effect on renal vascular tone, both in renal autografts and homo-
grafts.13 Glucocorticoids have not been shown to affect tubular transport of PAIl 
directly.20 However, studies with kidney slices in vitro showed inhibition of P AH 
uptake by 9-alpha-fluorohydrocortisone. 21 
The discrepancy between OCR and lf~ after prednisolone infusion leading to 
a significant decrease in OrR could be secondary to interference with tubular 
eIN 
transport of creatinine. This obsenation emphasizes the fact that changes in OCR 
associated with the administration of large doses of glucocorticoids do not reflect 
necessarily the true variation in GFR. Several substances are known to inhibit 
tubular secretion of creatinine (P AH in high doses and carinamide22 ), however, 
glucorticoids have not been known to have a similar effect. 
The changes in urinar-y excretion of Na following acute administration of 
glucocorticoids in normal subjects have been reported to be minimal 'when 
compared with those following the administration of mineralcorticoids.14, 23 In 
many instances, the obsened increase in Na excretion following glucocorticoids 
was associated with an increase in GFR and ,,,as attributed to the resulting in-
crease in the filtered load of Na.24-27 However, in other studies, significant changes 
in Na excretion were not associated with appreciable changes in GFR.11- 12 
The comparison of our data with those reported by others is difficult for 
several reasons. The doses of glucocorticoids used in other studies were consider-
ably smaller. The clearance determinations were not made at comparable time 
intervals to ours, and, occasionally, the first hour was excluded from the study.28 
In this study, the changes in fractional excretion of Na (ON.") were significant 
Orx 
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and followed a biphasic curve: initial increase and late decrease. The initial 
increase in CXa cannot be explained on the basis of increased filtered load of Na 
Cf~ 
as GFR decreased during the first hour and serum Na concentration did not 
change. It seems unlikely also that prednisolone could affect the aldosterone-
controlled tubular handling of Na in that short time. It appears, therefore, that 
factors other than GFR and aldosterone were involved. 
Variations in extracellular fluid volume play an important role in the regula-
tion of tubular Na reabsorption.29 Glucocorticoids have been shown to increase 
acutely extracellular fluid volume in dehydrated dogs, probably by a shift of salt 
and water from intracellular to extracellular compartments. 30 However, no in-
formation is available regarding the acute effect of glucocorticoids on extra-
cellular volume in human beings. Intravenous administration of glucocorticoids31 
to normal subjects induced an acute increase in cardiac output and decrease in 
peripheral vascular resistance. Increase in cardiac output, even without notice-
able changes in GFR and renal plasma flow, may increase renal excretion of 
Na.32 Another possibility could be that glucocorticoids depress tubular reabsorp-
tion of Na directly, leading to an early increase in CX" . The delayed decrease in 
Cr-x 
CNa (during the third postinfusion hour) could result from enhanced Na 
elN 
reabsorption in the distal tubule. Recent micropuncture studies provide evidence 
which supports the above possibility.33 
The striking increase in fractional excretion of K (CK), both in normal 
Crx 
subjects and in patients, was similar to that reported by othersY' 14, 34-36 Like 
others, we also noticed dissociation between the variation in Na and K excretory 
patterns.35,36 The reported observation37 that Na retention following glucocorti-
coids administration could be blocked by spironolactone, but the latter failed to 
affect K excretion is consistent with the notion that the glucocorticoid-induccd 
kaliuresis is not determined solely by Na+-K+ exchange mechanism. 
Several authors have maintained that thc increased excretion of K following 
the administration of glucocorticoids was secondary to an attendant increase in 
serum K+ concentration possibly due to a release of K+ from the intracellular 
space.35 ,36 In the prescnt study, we were unable to observe any significant 
changes in serum K levels. 
The observed rise in Cp in the present study was minimal and of short 
CIN 
duration. The reports on acute effect of glucorcorticoids on renal handling of P 
are controversial. Mills and Thomas38 noticcd an acute decrease in P excretion 
accompanied by a decrease in serum P concentration. The latter was attributed 
by the authors to an increased cellular uptake of P. Others reported an acute 
decrease in Tmp both in animals and humans, following acute administration of 
glucocorticoids.39- 41 Hydrocortisone produced phosphaturia in intact rats but not 
in parathyroidectomized animals. However, large doses of hydrocortisone induced 
phosphaturia also in absence of parathyroid glands!2 
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Renal handling of Ca and Mg has not been shown to be altered by acute 
administration of glucocorticoids.28 , 34 However, recent study demonstrated that 
the presence of excess glucocorticoids, either from exogenous or from endogenous 
source, decreased the calciuretic response to Ca infusion.43 Small but significant 
decreases in fractional excretions of Ca and Mg were noticed in our study only 
in the normal individuals. These changes were not associated with significantly 
altered ultrafiltrable serum fractions of Ca and Mg; however, because of the 
decrease in GFR, the filtered loads of Ca and Mg were reduced as welL The above 
changes in the fractional excretions of Ca and Mg were absent in the patients 
despite comparable decreases in GFR. It is possible, therefore, that the pre-
existing effect of maintenance glucocorticoids in the patients precluded further 
response to intravenous prednisolone. 
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